Goldman Sachs lowered the firm’s price target on Allstate (ALL) to $227 from $243 and keeps a Buy rating on the shares. In a sector note on Americas Insurance, the firm said it expects “strong and fairly resilient” insurer profitability for the next few years, but added that it believes we are “solidly in the softening phase” of the P&C insurance cycle, which leads to “increased capital supply and competition, which should drive a deceleration in growth/pricing/margins, that we think are broadly underappreciated within Street estimates.”
Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ALL:
- Allstate price target lowered to $225 from $233 at Evercore ISI
- Allstate price target raised to $254 from $250 at Keefe Bruyette
- Allstate price target raised to $313 from $300 at BofA
- Private Markets: OpenAI seeks to raise as much as $100B at $830B valuation
- Micron upgraded, PayPal downgraded: Wall Street’s top analyst calls
